Herbalife Ltd. (NYSE:HLF) Director Buys $289,500.00 in Stock

Herbalife Ltd. (NYSE:HLF - Get Free Report) Director Donal L. Mulligan bought 30,000 shares of the firm's stock in a transaction dated Friday, May 3rd. The shares were acquired at an average price of $9.65 per share, for a total transaction of $289,500.00. Following the transaction, the director now directly owns 60,000 shares in the company, valued at $579,000. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Herbalife Stock Performance

Shares of HLF stock traded up $0.15 on Monday, hitting $9.73. 2,688,788 shares of the stock traded hands, compared to its average volume of 2,240,292. Herbalife Ltd. has a twelve month low of $6.68 and a twelve month high of $19.48. The stock has a market capitalization of $972.71 million, a PE ratio of 6.99 and a beta of 1.24. The firm's 50-day moving average price is $8.82 and its two-hundred day moving average price is $11.52.

Herbalife (NYSE:HLF - Get Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. The business had revenue of $1.30 billion during the quarter, compared to analysts' expectations of $1.26 billion. Herbalife had a net margin of 2.70% and a negative return on equity of 19.97%. The business's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.54 EPS. On average, equities research analysts anticipate that Herbalife Ltd. will post 1.69 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Mizuho decreased their price target on shares of Herbalife from $12.00 to $10.00 and set a "neutral" rating on the stock in a research note on Thursday, March 21st. StockNews.com upgraded Herbalife from a "hold" rating to a "buy" rating in a research report on Friday, February 16th. DA Davidson reaffirmed a "neutral" rating and set a $9.50 target price on shares of Herbalife in a research note on Thursday. Finally, Bank of America decreased their price target on shares of Herbalife from $10.00 to $8.00 and set an "underperform" rating on the stock in a research note on Thursday, March 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $10.50.

Hedge Funds Weigh In On Herbalife

Hedge funds have recently made changes to their positions in the stock. PEAK6 Investments LLC purchased a new position in shares of Herbalife during the third quarter worth approximately $146,000. DGS Capital Management LLC acquired a new stake in Herbalife in the fourth quarter valued at $165,000. Hollencrest Capital Management grew its stake in shares of Herbalife by 21.3% during the 1st quarter. Hollencrest Capital Management now owns 17,100 shares of the company's stock worth $172,000 after purchasing an additional 3,000 shares during the period. SG Americas Securities LLC purchased a new stake in Herbalife during the fourth quarter worth about $184,000. Finally, Corton Capital Inc. increased its holdings in Herbalife by 10.2% in the third quarter. Corton Capital Inc. now owns 17,849 shares of the company's stock valued at $250,000 after buying an additional 1,654 shares in the last quarter.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.